Zevalin

Zevalin

Basic Prescribing Info
Contents
Ibritumomab tiuxetan
MIMS Class
Targeted Cancer Therapy
ATC Classification
V10XX02 - ibritumomab tiuxetan (90Y) ; Belongs to the class of various therapeutic radiopharmaceuticals.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in